Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients

Obstetrics and Gynecology

Volumn 101, Issue 2, 2003, Pages 258-263

  Sebire, N J ^a,b   Backos, M ^a   El Gaddal, S ^a   Goldin, R D ^a   Regan, L ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFARCTION; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RECURRENT ABORTION; RISK FACTOR; SPONTANEOUS ABORTION; VASCULAR DISEASE;

ABORTION, HABITUAL; ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; COHORT STUDIES; FEMALE; FETAL DEATH; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; MATERNAL AGE; PLACENTA; PLACENTAL INSUFFICIENCY; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PREVALENCE; PROBABILITY; RISK ASSESSMENT; RISK FACTORS;

EID: 0037311504     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02385-2     Document Type: Article

References (24)

1. Regan L. Recurrent miscarriage. BMJ. 302:1991;543-544.
2. Clifford K., Rai R., Watson H., Regan L. An informative protocol for the investigation of recurrent miscarriage Preliminary experience of 500 consecutive cases . Hum Reprod. 9:1994;1328-1332.
3. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome Report of an international workshop . Arthritis Rheum. 42:1999;1309-1311.
4. Backos M., Rai R., Baxter N., Chilcott I.T., Cohen H., Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol. 106:1999;102-107.
5. Rai R., Cohen H., Dave M., Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 314:1997;253-257.
6. Rai R., Clifford K., Regan L. The modern preventative treatment of recurrent miscarriage. Br J Obstet Gynaecol. 103:1996;106-110.
7. Rai R., Backos M., Baxter N., Chilcott I., Regan L. Recurrent miscarriage - an aspirin a day? Hum Reprod. 15:2000;2220-2223.
8. The Royal College of Pathologists. Fetal and perinatal pathology Report of a joint working party. 2000;RCOG Press, London.
9. Langston C., Kaplan C., MacPherson T., Manci E., Peevy K., Clark B., et al. Practice guideline for examination of the placenta Developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists . Arch Pathol Lab Med. 121:1997;449-476.
10. Fox H. Pathology of the placenta. 2nd ed: 1997;W.B. Saunders, London.
11. Salafia C.M., Thorp J., Starzyk K.A. Placental pathology in spontaneous prematurity. Kingdom J., Jauniaux E., O'Brien S. The placenta Basic science and clinical practice . 2000;169-186 RCOG Press, London.
12. Abramowsky C.R., Vegas M.E., Swinehart G., Gyves M.T. Decidual vasculopathy of the placenta in lupus erythematosus. N Engl J Med. 303:1980;668-672.
13. Dewolf F., Carreras L.O., Moerman P., Vermylen J., Vanassche A., Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol. 142:1982;829-834.
14. Hanly J.G., Gladman D.D., Rose T.H., Laskin C.A., Urowitz M.B. Lupus pregnancy. A prospective study of placental changes. Arthritis Rheum. 31:1988;358-366.
15. Salafia C.M., Parke A.L. Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome. Rheum Dis Clin North Am. 23:1997;85-97.
16. Levy R.A., Avvad E., Oliveira J., Porto L.C. Placental pathology in antiphospholipid syndrome. Lupus. 7:(Suppl 2):1998;S81-85.
17. Magid M.S., Kaplan C., Sammaritano L.R., Peterson M., Druzin M.L., Lockshin M.D. Placental pathology in systemic lupus erythematosus A prospective study . Am J Obstet Gynecol. 179:1998;226-234.
18. Ackerman J., Gonzalez E.F., Gilbert-Barness E. Immunological studies of the placenta in maternal connective tissue disease. Pediatr Dev Pathol. 2:1999;19-24.
19. Ogishima D., Matsumoto T., Nakamura Y., Yoshida K., Kuwabara Y. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies. Pathol Int. 50:2000;224-229.
20. Stone S., Khamashta M.A., Poston L. Placentation, antiphospholipid syndrome and pregnancy outcome. Lupus. 10:2001;67-74.
21. Sebire N.J., Jolly M., Harris J., Nicolaides K.H., Regan L. Risks of obstetric complications in multiple pregnancies An analysis of more than 400,000 pregnancies in the UK . Prenat Neonat Med. 6:2001;89-94.
22. Jolly M., Sebire N., Harris J., Robinson S., Regan L. The risks associated with pregnancy in women aged 35 years or older. Hum Reprod. 15:2000;2433-2437.
23. Donohoe S., Kingdom J.C.P., Mackie I.J. Affinity purified human antiphospholipid antibodies bind normal term pla-centa. Lupus. 8:1999;525-531.
24. Kingdom J., Jauniaux E., O'Brien S. Recommendations arising from the 38th Study Group: The Placenta Basic science and clinical practice . Kingdom J., Jauniaux E., O'Brien S. The placenta: Basic science and clinical practice. 2000;357-361 RCOG Press, London.